Senator Robert Menendez recently visited Rutgers Cancer Institute to learn about the important work being done as well as to discuss the impact of proposed budget cuts to the National Institutes of Health and scientific research.
From left: Dr. Steven Libutti, Director of Rutgers Cancer Institute of New Jersey, Vice Chancellor for Cancer Programs, RBHS, and Senior Vice President, Oncology Services, RWJBarnabas Health; Dee Sparacio, Cancer Survivor/Patient Advocate and Rutgers Cancer Institute patient; U.S. Senator Robert Menendez; Dr. Gary Aston Jones, Director, Rutgers Brain Health Institute; and Dr. Mark Ciracusa, young investigator, Chancellor Scholar, Rutgers Robert Wood Johnson Medical School, pose for a picture during Senator Menendez's visit to Rutgers Cancer Institute.
View the video of the day's remarks (courtesty of Senator Menendez)
(Top) Senator Melendez visits the laboratory of Dr. Eileen White, Chief Scientific Officer and Deputy Director of Rutgers Cancer Institute. (Center) Dr. Eileen White and Dr. Janice Mehnert, Director Phase I/ Investigational Therapeutics Program, present how beneficial funding has been to Rutgers Cancer Institute. (Bottom) Senator Menendez visits with Michael Kane, Director of Pharmacy and Dr. Steven Libutti, Director of Rutgers Cancer Institute.
(Top, Center) Senator Menendez discusses the need for support of continued funding of the National Institutes of Health. (Bottom) Dr. Steven Libutti thanks Senator Menendez for his support and addresses the crowd.
Dee Sparacio (left), cancer survivor, attests to the importance of funding clinical trials and thanks Senator Menendez for his support of funding the National Institutes of Health.
High resolution images available through Michele Fisher